A Non-interventional, Longitudinal, Medical Chart Review Study to Characterize Fezolinetant Use, Treatment Patterns and Patient Characteristics of Women Treated for Vasomotor Symptoms in the Private Healthcare Setting in Spain (CARMEN)

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS1000000953
• Study ID:
  1000000953
• Official title and acronym:
  A Non-interventional, Longitudinal, Medical Chart Review Study to Characterize Fezolinetant Use, Treatment Patterns and Patient Characteristics of Women Treated for Vasomotor Symptoms in the Private Healthcare Setting in Spain (CARMEN)
• DARWIN EU® study:
  No
• Study countries:
  Spain
• Study description:
  This study is about women in Spain who are in menopause. They had symptoms including hot flashes and night sweats (also known as vasomotor symptoms or VMS). Their own doctor had prescribed them fezolinetant for hot flashes and night sweats, as part of routine health care in Spain.; This study is about collecting information only.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Astellas Pharma Europe Ltd.

Study timelines

Date when funding contract was signed

Actual:08/10/2025

Study start date

Actual:18/06/2026

Data analysis start date

Planned:05/01/2027

Date of final study report

Planned:01/07/2027

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Astellas Pharma Europe Ltd.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

2693-MA-3693